GB SCIENCES INC financial data

Location
Las Vegas, NV
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2024 - 12 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.8 % -62%
Debt-to-equity -102 % +3.3%
Return On Equity 18.5 % -77.1%
Return On Assets -763 % -185%
Operating Margin -873 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 407M shares
Common Stock, Shares, Outstanding 407M shares +0.25%
Entity Public Float 4M USD -64.6%
Common Stock, Value, Issued 40.8K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 407M shares +0.97%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 97.2K USD
Cost of Revenue 0 USD
General and Administrative Expense 164K USD -30%
Operating Income (Loss) -848K USD +46.3%
Nonoperating Income (Expense) -195K USD +91.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.04M USD +72.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.04M USD +72.3%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.02K USD -82.7%
Assets, Current 94.5K USD -35.8%
Assets 103K USD -70.6%
Accrued Liabilities, Current 146K USD +92.4%
Liabilities, Current 5.42M USD +10.1%
Liabilities 5.97M USD +19.6%
Retained Earnings (Accumulated Deficit) -111M USD -0.95%
Stockholders' Equity Attributable to Parent -5.88M USD -21.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -5.88M USD -21.3%
Liabilities and Equity 94.5K USD -35.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22K USD +79.1%
Net Cash Provided by (Used in) Financing Activities 10K USD -60%
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 407M shares +0.25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -12K USD +85.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 110K USD -53%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 14.1M USD -2.97%
Deferred Tax Assets, Gross 14.1M USD -2.97%
Deferred Tax Assets, Operating Loss Carryforwards 11.1M USD +1.14%
Additional Paid in Capital 105M USD +0.01%
Amortization of Intangible Assets 0 USD -100%
Interest Expense 183K USD -32.7%